(-)-epigallocatechin 3-gallate/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases LDL cholesterol
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×1“According to weighted mean differences for changes from baseline with 95% confidence intervals (CI), 107-856 mg/d of EGCG for 4 to 14 weeks reduced LDL-C by -9.29 mg/dl (95% CI, -12.27 to -6.31).”
Quoted verbatim from Systematic review of green tea epigallocatechin gallate in reducing low-density lipoprotein cholesterol levels of humans.. - Study
- meta-analysis
- Dose
- 107-856 mg/d for 4 to 14 weeks
- Population
- healthy individuals, pooled across 17 randomized controlled trials of EGCG for 4 to 14 weeks
Effect -9.29 mean difference, 95% CI -12.27 to -6.31
Systematic review of green tea epigallocatechin gallate in reducing low-density lipoprotein cholesterol levels of humans.2016PMID:27324590Permalink
Keep reading
- Everything the graph holds on (-)-epigallocatechin 3-gallate
- Every compound studied against LDL cholesterol
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M2SKT9KD8CM25X2WFTNFDKEA